Download this free whitepaper to learn how Clinical Ink’s ePRO technology, Engage, brings a timely, easy-to-implement, cost-effective solution to Phase 1 studies.
This free whitepaper will demonstrate how Clinical Ink’s ePRO technology, Engage, can solve long-standing issues with paper-based Phase I clinical trials, including the lack of data attributability, the inability to monitor patient activity in real-time and the time it takes to transcribe subject reported data into an ECF.
Read this whitepaper to learn how Engage revolutionizes Phase I trials with:
Clinical Ink’s eSource platform supports the full range of validated ePRO questionnaires and eCOA-based CliniROs, ObsROs, PerfOs and Structured Diagnostic Interviews for both site- and home-based settings. The platform provides complete support for protocol requirements, offers regularly scheduled data transfers and has been deployed for use in all phases of clinical trials and across a wide range of therapeutic areas. Clinical Ink University also provides full-service training by web or at your site
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Our eSource clinical technology and configurable ePRO and eCOA modules — a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source — naturally enhance your clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as your trials progress. Accelerate the completion of key clinical development milestones in your study and confidently manage your trial’s critical decisions with our flexible menu of collaborative services, remote monitoring support, and a complete, real-time view of your trial.